Nucleus

Grammarly Delivers a 1994% ROI for Databricks According to Nucleus Research ROI Case Study

Retrieved on: 
Wednesday, February 28, 2024

Nucleus Research announced the findings of a study into the benefits that technology vendor Databricks realized from implementing AI writing assistance solution Grammarly .

Key Points: 
  • Nucleus Research announced the findings of a study into the benefits that technology vendor Databricks realized from implementing AI writing assistance solution Grammarly .
  • Nucleus found that Grammarly delivered a 1994 percent Return on Investment (ROI) for Databricks, which was able to recover its initial investment in the solution just 1.2 months after deployment.
  • “After deploying Grammarly, Databricks saw immediate benefits such as productivity and writing quality improvements from the solution’s AI-driven suggestions and accelerated review processes.”
    Key benefits highlighted in the case study include:
    Accelerated Writing & Editing.
  • After deploying Grammarly, Databricks was able to save nearly $8,000 in employee productivity annually across the support engineer hiring process.

Qualtrics Customers Achieve a 100% ROI with an Average Payback of 1.5 Years According to Nucleus Research ROI Guidebook

Retrieved on: 
Thursday, February 22, 2024

Nucleus Research published an ROI guidebook examining the benefits of deploying experience management software provider, Qualtrics .

Key Points: 
  • Nucleus Research published an ROI guidebook examining the benefits of deploying experience management software provider, Qualtrics .
  • Nucleus interviewed multiple Qualtrics customers and found the solution delivered an average ROI of 100 percent, with an average annual benefit of $6.3 million and an average payback period of 1.5 years.
  • “Qualtrics’ CrossXM offering brings together customer experience (CX) and employee experience (EX) data and processes to improve decision-making and maximize business impact across experiences.”
    Key benefits highlighted in the guidebook include:
    Increased revenue.
  • To read the full Qualtrics ROI Guidebook, click here .

Nucleus Security Raises $43 Million Series B Funding to Lead Innovation in Enterprise Risk-Based Vulnerability Management

Retrieved on: 
Monday, February 12, 2024

SARASOTA, Fla., Feb. 12, 2024 /PRNewswire/ -- Nucleus Security, developers of the market-leading Risk-Based Vulnerability Management platform, has announced it has secured $43 million in Series B funding led by Arthur Ventures and Lead Edge Capital.

Key Points: 
  • SARASOTA, Fla., Feb. 12, 2024 /PRNewswire/ -- Nucleus Security, developers of the market-leading Risk-Based Vulnerability Management platform, has announced it has secured $43 million in Series B funding led by Arthur Ventures and Lead Edge Capital.
  • "We are thrilled to announce our continued partnership with Nucleus Security during this phase of tremendous growth.
  • The Company has emerged as the innovation leader within the vulnerability and risk management space and has demonstrated unparalleled success transforming vulnerability management programs for large enterprises in nearly every market.
  • To see how Nucleus can transform your organization's vulnerability and risk management program, visit https://nucleussec.com for a free 30-day trial.

Planful Maintains Global Expansion Momentum in 2023

Retrieved on: 
Thursday, February 8, 2024

SAN FRANCISCO, Feb. 8, 2024 /PRNewswire/ -- Planful Inc., the pioneer of financial performance management cloud software, today announced strong customer, revenue, and bookings growth in fiscal year 2023, capped by record-breaking bookings in the fourth quarter of 2023.

Key Points: 
  • The continued momentum was fueled by the addition of hundreds of new customers along with expansion of Planful solutions deeper into its existing customer base.
  • For the fourth quarter, Planful achieved record new bookings growth across several key metrics, including:
    Grant Halloran, Planful Chief Executive Officer, said: "2023 was a tough year in the SaaS market, and I'm very proud of our team's resiliency and excellent performance.
  • We welcomed many new customers and supported existing ones as they expanded their use of Planful with our AI accelerator, Planful Predict, and by increasing usage across their business users, with experiences built specifically for budget managers.
  • Planful lets us be true partners to the business, working together to drive peak performance at Otter Products."

HiBob Sustains Excellence Record Securing Four Brandon Hall Group Tech Awards Second Year in a Row

Retrieved on: 
Wednesday, January 31, 2024

The Brandon Hall Group's Fall Technology Excellence Awards recognize outstanding work in areas like learning, talent management, and HR.

Key Points: 
  • The Brandon Hall Group's Fall Technology Excellence Awards recognize outstanding work in areas like learning, talent management, and HR.
  • "In our 30th year, the Excellence in Technology Awards continue to showcase the best innovations in learning, talent management, talent acquisition, HR, workforce management, and sales enablement technologies.
  • "In 2023, HiBob remained committed to innovating people management services for its customers," said Ronni Zehavi, Co-founder and CEO at HiBob.
  • The successful integration of HiBob Human Capital Management (HCM) led to an impressive 301 percent return on investment, earning Oviva recognition at the Nucleus ROI Awards.

Zendesk Users Report a 43% Lower Total Cost of Ownership than Salesforce According to Nucleus Research Report

Retrieved on: 
Tuesday, January 23, 2024

Nucleus Research published a report assessing Zendesk user’s experience with the CRM platform to determine the incremental value of transitioning to Zendesk from Salesforce Service Cloud.

Key Points: 
  • Nucleus Research published a report assessing Zendesk user’s experience with the CRM platform to determine the incremental value of transitioning to Zendesk from Salesforce Service Cloud.
  • Zendesk users reported the platform’s ease of use, platform adaptability and agility, and value delivered relative to cost were the primary components driving their selection.
  • Nucleus found these attributes translated to faster time to value, a 43 percent reduction in TCO, and elevated customer experience management.
  • Users report that the implementation of Zendesk is 53.7% faster than that of Salesforce Service Cloud.

New Study Further Demonstrates Value of Paycom’s Beti Payroll Solution

Retrieved on: 
Thursday, January 18, 2024

The commissioned study also found three typical benefit areas stemming from Paycom’s single HR software featuring Beti, including reduced errors, increased payroll productivity and improved employee engagement.

Key Points: 
  • The commissioned study also found three typical benefit areas stemming from Paycom’s single HR software featuring Beti, including reduced errors, increased payroll productivity and improved employee engagement.
  • A leader within the restaurant industry told Nucleus the automation from Beti took days off payroll processing time.
  • “Beti is a paradigm shift for the payroll industry, and the value of perfect payroll is showing tremendous ROI for our clients,” said Chad Richison, founder, chairman and CEO of Paycom.
  • With Paycom’s payroll solution, clients reduced time spent processing payroll by upward of 90%.

Core Biogenesis and Nucleus Biologics Announce Strategic Collaboration for Manufacturing and Distribution of Cost-Effective and Sustainable Recombinant Proteins

Retrieved on: 
Wednesday, January 10, 2024

This agreement makes Nucleus Biologics the GMP manufacturer for Core Biogenesis’ recombinant proteins and a distributor for the cell and gene therapy market.

Key Points: 
  • This agreement makes Nucleus Biologics the GMP manufacturer for Core Biogenesis’ recombinant proteins and a distributor for the cell and gene therapy market.
  • In addition, Nucleus Biologics, along with their sister company Stoic Bio , will make these recombinant proteins available for their Krakatoa™ pod-based media manufacturing systems.
  • Nucleus Biologics and Core Biogenesis are poised to demonstrate that developing and manufacturing lifesaving therapies doesn’t have to come with a heavy environmental cost.
  • The Core Biogenesis and Nucleus Biologics collaboration will create a truly unique service offering that will introduce a paradigm shift in development and manufacturing to the entire industry.

Bread Financial Achieves 75% ROI by Implementing BrightPlan According to Nucleus Research ROI Case Study

Retrieved on: 
Wednesday, January 10, 2024

Nucleus Research announced the findings of a study into the benefits that financial services provider, Bread Financial realized from implementing financial wellness solution, BrightPlan .

Key Points: 
  • Nucleus Research announced the findings of a study into the benefits that financial services provider, Bread Financial realized from implementing financial wellness solution, BrightPlan .
  • This delivered a 75 percent Return on Investment (ROI) for Bread Financial who was able to recover its initial investment in the solution just 2.1 years after deployment.
  • We began searching for a better suited financial wellness offering with the goal of improving associate experience and reducing financial stressors across our workforce,” said a spokesperson from Bread Financial.
  • Upon the implementation of BrightPlan, Bread Financial was able to reduce its annual turnover rate by 22%, retaining approximately 336 associates annually.

Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Retrieved on: 
Thursday, December 14, 2023

Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer.

Key Points: 
  • Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer.
  • As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi and Pfizer, Ms. Spencer-Pike will be responsible for accelerating the growth of the startup following its oversubscribed $56M Series A in October.
  • Ms. Spencer-Pike follows a string of C-Suite appointments including Geoff Johnson, M.D., Ph.D. as Chief Scientific Officer, Kevin Haehl as Chief Development Officer and Mark Przekop as Chief Operating Officer.
  • Ms. Spencer-Pike previously was VP, Commercial Leader for Novo Nordisk, successfully leading the planning, development and execution of market and sales strategies, exceeding revenue goals.